LIMES SCHLOSSKLINIKEN AG (LIK.DE) Stock Fundamental Analysis

FRA:LIK • DE000A0JDBC7

486 EUR
-2 (-0.41%)
Last: Feb 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

LIK gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 29 industry peers in the Health Care Providers & Services industry. LIK scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LIK is valued quite expensively, but it does show have an excellent growth rating. These ratings would make LIK suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year LIK was profitable.
  • Of the past 5 years LIK 4 years were profitable.
  • In multiple years LIK reported negative operating cash flow during the last 5 years.
LIK.DE Yearly Net Income VS EBIT VS OCF VS FCFLIK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • LIK's Return On Assets of 10.51% is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 20.85%, LIK belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
  • LIK's Return On Invested Capital of 15.26% is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LIK is significantly above the industry average of 6.49%.
Industry RankSector Rank
ROA 10.51%
ROE 20.85%
ROIC 15.26%
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
LIK.DE Yearly ROA, ROE, ROICLIK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

  • With an excellent Profit Margin value of 10.81%, LIK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of LIK has declined.
  • LIK has a better Operating Margin (16.42%) than 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of LIK has declined.
  • LIK's Gross Margin of 95.03% is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
  • LIK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.42%
PM (TTM) 10.81%
GM 95.03%
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
LIK.DE Yearly Profit, Operating, Gross MarginsLIK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LIK is creating value.
  • Compared to 1 year ago, LIK has about the same amount of shares outstanding.
  • The number of shares outstanding for LIK remains at a similar level compared to 5 years ago.
  • LIK has a better debt/assets ratio than last year.
LIK.DE Yearly Shares OutstandingLIK.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K 200K 250K
LIK.DE Yearly Total Debt VS Total AssetsLIK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 6.25 indicates that LIK is not in any danger for bankruptcy at the moment.
  • LIK has a better Altman-Z score (6.25) than 100.00% of its industry peers.
  • LIK has a Debt/Equity ratio of 0.56. This is a neutral value indicating LIK is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.56, LIK belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z 6.25
ROIC/WACC2.13
WACC7.15%
LIK.DE Yearly LT Debt VS Equity VS FCFLIK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 3.25 indicates that LIK has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.25, LIK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Quick Ratio of 3.23 indicates that LIK has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.23, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.25
Quick Ratio 3.23
LIK.DE Yearly Current Assets VS Current LiabilitesLIK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • LIK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.76%.
  • The Earnings Per Share has been decreasing by -7.60% on average over the past years.
  • The Revenue has decreased by -0.13% in the past year.
  • LIK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.58% yearly.
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%

3.2 Future

  • Based on estimates for the next years, LIK will show a very strong growth in Earnings Per Share. The EPS will grow by 36.66% on average per year.
  • LIK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.37% yearly.
EPS Next Y9.79%
EPS Next 2Y33.32%
EPS Next 3Y36.66%
EPS Next 5YN/A
Revenue Next Year13.89%
Revenue Next 2Y21.91%
Revenue Next 3Y21.37%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LIK.DE Yearly Revenue VS EstimatesLIK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
LIK.DE Yearly EPS VS EstimatesLIK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2024 2025 2026 2027 0 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 31.01, which means the current valuation is very expensive for LIK.
  • Compared to the rest of the industry, the Price/Earnings ratio of LIK indicates a slightly more expensive valuation: LIK is more expensive than 72.41% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.18, LIK is valued at the same level.
  • LIK is valuated correctly with a Price/Forward Earnings ratio of 15.43.
  • The rest of the industry has a similar Price/Forward Earnings ratio as LIK.
  • LIK's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.01.
Industry RankSector Rank
PE 31.01
Fwd PE 15.43
LIK.DE Price Earnings VS Forward Price EarningsLIK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LIK is valued a bit more expensive than the industry average as 72.41% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.59
LIK.DE Per share dataLIK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LIK does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of LIK may justify a higher PE ratio.
  • LIK's earnings are expected to grow with 36.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.17
PEG (5Y)N/A
EPS Next 2Y33.32%
EPS Next 3Y36.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LIK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIMES SCHLOSSKLINIKEN AG

FRA:LIK (2/11/2026, 7:00:00 PM)

486

-2 (-0.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-03
Earnings (Next)N/A
Inst Owners7.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap140.94M
Revenue(TTM)42.54M
Net Income(TTM)4.60M
Analysts80
Price Target612 (25.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-29.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.93%
Valuation
Industry RankSector Rank
PE 31.01
Fwd PE 15.43
P/S 3.31
P/FCF N/A
P/OCF N/A
P/B 6.39
P/tB 10.03
EV/EBITDA 14.59
EPS(TTM)15.67
EY3.22%
EPS(NY)31.49
Fwd EY6.48%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS146.68
BVpS76.04
TBVpS48.46
PEG (NY)3.17
PEG (5Y)N/A
Graham Number163.73
Profitability
Industry RankSector Rank
ROA 10.51%
ROE 20.85%
ROCE 18.69%
ROIC 15.26%
ROICexc 21.72%
ROICexgc 31.24%
OM 16.42%
PM (TTM) 10.81%
GM 95.03%
FCFM N/A
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
ROICexc(3y)23.25%
ROICexc(5y)N/A
ROICexgc(3y)57.5%
ROICexgc(5y)N/A
ROCE(3y)18.77%
ROCE(5y)N/A
ROICexgc growth 3Y-31.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y-14.79%
ROICexc growth 5YN/A
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
F-ScoreN/A
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Debt/EBITDA 1.26
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.25
Quick Ratio 3.23
Altman-Z 6.25
F-ScoreN/A
WACC7.15%
ROIC/WACC2.13
Cap/Depr(3y)160.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)11.64%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
EPS Next Y9.79%
EPS Next 2Y33.32%
EPS Next 3Y36.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%
Revenue Next Year13.89%
Revenue Next 2Y21.91%
Revenue Next 3Y21.37%
Revenue Next 5YN/A
EBIT growth 1Y28.44%
EBIT growth 3Y-1.81%
EBIT growth 5YN/A
EBIT Next Year61.61%
EBIT Next 3Y44.28%
EBIT Next 5Y29.34%
FCF growth 1Y890.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3YN/A
OCF growth 5YN/A

LIMES SCHLOSSKLINIKEN AG / LIK.DE FAQ

What is the ChartMill fundamental rating of LIMES SCHLOSSKLINIKEN AG (LIK.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to LIK.DE.


What is the valuation status for LIK stock?

ChartMill assigns a valuation rating of 3 / 10 to LIMES SCHLOSSKLINIKEN AG (LIK.DE). This can be considered as Overvalued.


How profitable is LIMES SCHLOSSKLINIKEN AG (LIK.DE) stock?

LIMES SCHLOSSKLINIKEN AG (LIK.DE) has a profitability rating of 7 / 10.


What is the valuation of LIMES SCHLOSSKLINIKEN AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LIMES SCHLOSSKLINIKEN AG (LIK.DE) is 31.01 and the Price/Book (PB) ratio is 6.39.